Bk Virus Infection
📧 Sign up to get email alerts when something new happens for Bk Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-20Clinical Trial Update: Reduction of BK Viremia in Kidney Transplant Patients [NA]
This clinical trial update indicates the study on reducing BK viremia in kidney transplant patients has been withdrawn.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients [Phase 1]
This Phase 1 clinical trial at MD Anderson is evaluating the feasibility, safety, and efficacy of genetically engineered glucocorticoid rece…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Immune Registry for BK in Kidney Transplant Recipients
A clinical trial registry studying immune responses to BK virus in kidney transplant recipients; currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient [NA]
This clinical trial is evaluating whether everolimus with reduced-dose tacrolimus is more effective than reduced-dose tacrolimus with leflun…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Prediction of BK Virus Reactivation in Kidney Transplant Recipient [NA]
A completed clinical trial evaluating predictors of BK virus reactivation in kidney transplant recipients; the snippet does not provide resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus [Phase 2]
Phase 2 trial evaluating autologous cytotoxic T lymphocytes for BK virus and JC virus infections in immunocompromised patients (including AI…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients [Phase 2, Phase 3]
This clinical trial update indicates that Phase 2 and Phase 3 studies of AntiBKV for BK virus infection in kidney transplant recipients have…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. [Phase 1]
Phase 1 clinical trial evaluating TETRAVI Multivirus CTLs to treat EBV, CMV, adenovirus, and BK virus infections in patients after allogenei…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
A clinical trial is evaluating a monoclonal antibody–based therapy for BK virus infection, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation. [Phase 4]
Phase 4 trial evaluating whether intravenous immunoglobulins can prevent BK virus infection in kidney transplant recipients, stratified by B…
-
CLINICAL_TRIALS other · 2025-08-05Clinical Trial Update: TETRAVI Expanded Access Program
This is an update on the TETRAVI Expanded Access Program sponsored by Baylor College of Medicine, covering viral infections including Epstei…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections in Children and Young Adults [Phase 1]
Phase 1 trial evaluating R-MVST Cells for treatment of viral infections in children and young adults is currently recruiting, assessing safe…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections [Phase 1]
Phase 1 clinical trial evaluating R-MVST cells for the treatment of viral infections, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating donor-derived T lymphocytes for infections caused by adenovirus, cytomegalovirus, Epstein-Barr virus,…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: BK With VST for Kidney Transplant Patients [Phase 1]
Phase 1 trial evaluating virus-specific T cells (VST) for BK virus infection in kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation [Phase 2]
Phase 2 study to assess safety and tolerability of brincidofovir in kidney transplant recipients with BK virus infection (viremia); the tria…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis [Phase 1, Phase 2]
The document describes a Phase 1/2 clinical trial evaluating adoptive cord blood immunotherapy to prevent or treat reactivation/infection wi…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
A completed prospective study of BK virus disease after allogeneic hematopoietic-cell transplantation, aiming to define the disease's natura…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia [Phase 2]
Phase 2 study of Posoleucel (formerly ALVR105; Viralym-M) in kidney transplant patients with BK viremia has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reports termination of a Phase 2/Phase 3 study of posoleucel (ALVR105, Viralym-M) for multi-virus prevention in patien…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) [Phase 3]
Phase 3 study evaluating Viralym-M (ALVR105) for virus-associated hemorrhagic cystitis, including BK virus infection, was terminated with re…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reporting completed results for Posoleucel (ALVR105) studied to prevent multiple viral infections after allogeneic hem…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients [Phase 2]
Phase 2 trial update for MAU868 assessing safety, pharmacokinetics, and efficacy in BK virus infection among kidney transplant recipients ha…
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: CMX001 in Post-transplant Patients With BK Virus Viruria [Phase 1, Phase 2]
Clinical trial update for CMX001 in post-transplant patients with BK virus viruria (Phase 1/Phase 2) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Ciprofloxacin for Prevention of BK Infection [Phase 4]
Phase 4 clinical trial evaluating ciprofloxacin for prevention of BK virus infection completed.